Location: Home
  • search
  • go
  • Relate News
  • 10/25/2010Sinovac Biotech lowers revenue forecast for 2010
  • 10/25/2010SinoPharm confirm IPO plan for CNBG
  • 10/22/2010Essential drug policy under pressure for revision
  • 10/20/2010IMS: Review of the Chinese Hospital Drug Market MAT 2Q/2010
  • 10/20/2010China's new emerging industry support policy will benefit biopharmaceu...
  • 10/19/2010F&S: China possesses strategic advantage for drug discovery outsou...
  • 10/19/2010Surprise: SinoPharm acquires human resource management firm CNSC
  • 10/18/2010MOH establishes Expert Committee for Disease Prevention and Control
  • 10/16/2010Chinese vaccine market grew 21.5% CAGR in the past three years
  • 10/15/2010SinoPharm Group enters strategic alliance with Hubei province
  • 10/14/2010TaiGen amends nemonoxacin license agreement with Warner Chilcott
  • 10/14/2010MOH to experiment electronic medical records in 22 provinces
  • 10/13/2010Chinese manufacturers of Sibutramine hang on to their products for now
  • 10/12/2010Pfizer to pay US$3.6 billion for King Pharmaceuticals
  • 10/12/2010Chinese pharma industry continues high growth in first eight months of...
  • 10/11/2010Gloria Pharma agrees to purchase NCEs for Leukemia at CNY 65 million
  • 10/9/2010China's pharma trade expands nearly 30% in the first half
  • 10/9/2010Pfizer inaugurates new R&D center in Wuhan
  • 10/8/2010MOHRSS official moves
  • 10/7/2010IMS: global pharma market to grow 4%-5% this year
  • 10/7/2010IMS: China set to become the third largest drug market this year
  • 10/6/2010BioTrends report reveals clinical trends for renal anemia in China
  • 10/6/2010Chinese and British scientists work together to improve Artemisinin pr...
  • 10/6/2010GeneScience to plead guilty for illegal distribution of HGHs in the U....
  • 10/6/2010J&J reaches acquisition agreement with Crucell
  • 10/6/2010Asian CRO market to expand at 20% CAGR thru 2015
  • 10/6/2010Tasly and ProteoTech sign deal to co-develop Alzheimer's drug
  • 10/6/2010New trend of MNC R&D cost-cutting being shaped
  • 10/4/2010MOH official: government investment key to complete removal of hospita...
  • 10/4/2010BMI: Chinese pharma to grow 13.7% CAGR through 2014
  • Page:308/361 Total number of articles:10807: [First][<<] [306] [307] [308] [309] [310] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group